# Hemostemix Inc. — Form D

Hemostemix Inc. of BLACKFALDS, A0, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-14. The offering totals $132K. Industry: Biotechnology.

## Offering

- Filed: 2017-09-14
- Form: D
- Accession: 0001716567-17-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $132K
- Remaining: $132K
- Investors: 2
- Date of first sale: 2017-08-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-294665

## Issuer

- Name: Hemostemix Inc.
- CIK: 0001716567
- Entity type: Corporation
- Jurisdiction: ALBERTA, CANADA
- Incorporated: 2014
- Address: BAY 1, 5220 DUNCAN AVENUE, PO BOX 10, BLACKFALDS, A0, T0M 0J0
- Phone: 403-340-9207

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Don L Friesen | Director | Calgary, A0 |
| Angus Jenkins | Director | Calgary, A0 |
| David L Wood | Director | Naples, FL |
| David L Berman | Executive Officer | Thornhill, A6 |
| Kyle L Makofka | Executive Officer | Blackfalds, A0 |
| Ina L Sarel | Executive Officer | Ramat Gan, L3 |

## More

- [CIK 1716567 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1716567&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001716567-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.